Illumina Inc

XNASHealth care

Last traded price · USD

$240.00

+0.75%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 4 Nov 2026, 15:08 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $238.21
Volume: 1,056
Day's high: —
Day's low: —

In brief

Illumina Inc is a health care company listed on Nasdaq, valued at about $36.29B.
Its shares closed at $238.21 on 3 Nov 2026, up 98.5% over the past year.
From India you can buy ILMN in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Illumina Inc (ILMN) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole ILMN share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade ILMN options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Ahead of SPY and its sector fund XLV over 1 year
1 month: −18.9% (SPY −2.6%, XLV +9.9%). 3 months: +17.3% (SPY −2.2%, XLV +13.5%). 1 year: +98.5% (SPY +10.4%, XLV +27.4%). Price change to the 3 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: ILMN, SPY and XLV · as of 3 Nov 2026
Below its 50-day average, above its 200-day
The 3 Nov 2026 close of $238.21 was 4.6% below its 50-day average ($249.74) and 34.6% above its 200-day average ($176.99). It has closed above the 200-day for 262 sessions, since 20 Oct 2025. The 50-day average crossed above the 200-day on 29 Sep 2025, 276 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 3 Nov 2026
64% of the way up its 52-week range
Closed at $238.21 on 3 Nov 2026: 23.0% below the 52-week high of $309.35 (6 Oct 2026) and 111.5% above the low of $112.65 (12 Feb 2026).
Daily price bars, split-adjusted · as of 3 Nov 2026
Short interest at 5.2% of shares outstanding
7.9M shares were sold short at the 15 Oct 2026 settlement, 5.2% of the 151.0M shares outstanding; covering them would take 2.9 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 3 Nov 2026 close

1 month−18.9%

6 months+71.3%

1 year+98.5%

5 years−43.2%

Newswire

About

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Website

Notable moves

October 30, 2026
−18.64%
October 31, 2025
+24.78%
January 11, 2022
+16.98%

Illumina Inc

XNASHealth care

Last traded price · USD

$240.00

+0.75%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 4 Nov 2026, 15:08 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $238.21
Volume: 1,056
Day's high: —
Day's low: —

In brief

Illumina Inc is a health care company listed on Nasdaq, valued at about $36.29B.
Its shares closed at $238.21 on 3 Nov 2026, up 98.5% over the past year.
From India you can buy ILMN in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Illumina Inc (ILMN) shares from India?

Do I need the price of a whole ILMN share to invest?

How much can I invest in US stocks in a year?

Can I trade ILMN options or futures?

Insights

Quotes run fifteen minutes behind.

Ahead of SPY and its sector fund XLV over 1 year
1 month: −18.9% (SPY −2.6%, XLV +9.9%). 3 months: +17.3% (SPY −2.2%, XLV +13.5%). 1 year: +98.5% (SPY +10.4%, XLV +27.4%). Price change to the 3 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: ILMN, SPY and XLV · as of 3 Nov 2026
Below its 50-day average, above its 200-day
The 3 Nov 2026 close of $238.21 was 4.6% below its 50-day average ($249.74) and 34.6% above its 200-day average ($176.99). It has closed above the 200-day for 262 sessions, since 20 Oct 2025. The 50-day average crossed above the 200-day on 29 Sep 2025, 276 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 3 Nov 2026
64% of the way up its 52-week range
Closed at $238.21 on 3 Nov 2026: 23.0% below the 52-week high of $309.35 (6 Oct 2026) and 111.5% above the low of $112.65 (12 Feb 2026).
Daily price bars, split-adjusted · as of 3 Nov 2026
Short interest at 5.2% of shares outstanding
7.9M shares were sold short at the 15 Oct 2026 settlement, 5.2% of the 151.0M shares outstanding; covering them would take 2.9 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 3 Nov 2026 close

1 month−18.9%

6 months+71.3%

1 year+98.5%

5 years−43.2%

Newswire

About

Website

Notable moves

October 30, 2026
−18.64%
October 31, 2025
+24.78%
January 11, 2022
+16.98%

Illumina Inc

Illumina Inc in brief

Ahead of SPY and its sector fund XLV over 1 year

Below its 50-day average, above its 200-day

64% of the way up its 52-week range

Short interest at 5.2% of shares outstanding

Illumina Inc

Illumina Inc in brief

Ahead of SPY and its sector fund XLV over 1 year

Below its 50-day average, above its 200-day

64% of the way up its 52-week range

Short interest at 5.2% of shares outstanding